Fungal Biofilms
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Biofilms are a principal form of microbial growth and are critical to development of clinical infection. They are responsible for a broad spectrum of microbial infections in the human host. Many medically important fungi produce biofilms, including Candida [1], Aspergillus [2], Cryptococcus [3], Trichosporon [4], Coccidioides [5], and Pneumocystis [6]. In this review we emphasize common features among fungal biofilms, and point toward genes and pathways that may have conserved roles. Biofilm cell communities are more resistant to antifungal drugs than planktonic cells. Contributing factors include biofilm structural complexity, presence of extracellular matrix (ECM), metabolic heterogeneity intrinsic to biofilms, and biofilm-associated up-regulation of efflux pump genes. The actual fold increase in resistance varies with both the drug and species. Candida albicans and Candida parapsilosis biofilms are relatively resistant to fluconazole, amphotericin B, nystatin, voriconazole, and others. Aspergillus fumigatus biofilms are relatively resistant to itraconazole and, to some extent, to caspofungin. Cryptococcal biofilms are unaffected by fluconazole and voriconazole, and biofilms of Trichosporon asahii display elevated resistance to amphotericin B, caspofungin, voriconazole, and fluconazole. Azole and amphotericin B therapies are ineffective against Pneumocystis carinii biofilms. Biofilm-associated resistance mechanisms have been characterized in C. albicans and A. fumigatus and include drug binding by ECM and production of persister cells [2,7] (see supplementary references for this section in Text S1). Persister cells represent only a fraction of the population, and probably reflect its metabolic heterogeneity. These mechanisms may pertain to other fungi as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the single-celled morphology of yeasts also favours adhesion and biofilm formation, which directly influences environmental persistence, competitiveness and thereby improved biocontrol activity (Fanning and Mitchell 2012; Pandin et al. 2017; Rossouw et al. 2018; Verstrepen and Klis 2006).”
From Biocontrol yeasts: mechanisms and applications (2019) · cites this paper as Fanning and Mitchell 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612 · cited 6×
“ALS1 is the most upregulated of the known adherence genes of C. albicans under biofilm conditions. Garcia-Sanchez et al. (2004) [26] highlight that the ALS genes are differentially expressed in biofilms and have autonomous contributions in the biofilm transcriptome. Nett et al. (2009) [25] observed differential expres…”
BackgroundInfluentialSelf-citationAl-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389
García-Sánchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J.-M., & d'Enfert, C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.536-545.2004 · Cited by 353
Adherence and biofilm formation of non-Candida albicans Candida species
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.02.003 · Cited by 304
Candida albicans forms biofilms on the vaginal mucosa
Harriott, M. M., Lilly, E. A., Rodriguez, T. E., Fidel, P. L., & Noverr, M. C. (2010) · Microbiology · doi:10.1099/mic.0.039354-0 · Cited by 301
In vivo biofilm composition of Aspergillus fumigatus
Loussert, C., Schmitt, C., Prevost, M.-C., Balloy, V., Fadel, E., Philippe, B., Kauffmann-Lacroix, C., Latgé, J. P., & Beauvais, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01409.x · Cited by 269
Martins, M., Uppuluri, P., Thomas, D. P., Cleary, I. A., Henriques, M., Lopez-Ribot, J. L., & Oliveira, R. (2010) · Mycopathologia · doi:10.1007/s11046-009-9264-y · Cited by 250
Di Bonaventura, G., Pompilio, A., Picciani, C., Iezzi, M., D'Antonio, D., & Piccolomini, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-06 · Cited by 226
Cited by
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Essential Oils and Antifungal Activity
Nazzaro, F., Fratianni, F., Coppola, R., & Feo, V. D. (2017) · Pharmaceuticals · doi:10.3390/ph10040086 · Cited by 817
“Inhibition of biofilm development Coriandrum sativum [59] Croton cajucara [60,61] Cymbopogon [62–65] Cytrus [66] Eucalyptus [62] Laurus nobilis [67] Litsea [35] Melaleuca alternifolia [38,68,69] Mentha [62,70] Myrtus communis [71] Ocimum [72,73] Piper claussenianum [74] Rosmarinus officinalis [75] Inhibition of biofil…”
BackgroundInfluentialTariq, S., Wani, S., Rasool, W., Shafi, K., Bhat, M. A., Prabhakar, A., Shalla, A. H., & Rather, M. A. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103580 · Cited by 693
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Biocontrol yeasts: mechanisms and applications
Freimoser, F. M., Rueda-Mejia, M. P., Tilocca, B., & Migheli, Q. (2019) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-019-2728-4 · Cited by 462
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
“Biofilms are highly structured and complex microbial communities embedded in a self-produced extracellular matrix (ECM) that attach to a wide range of surfaces and (Fanning and Mitchell, 2012).”
BackgroundLarkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda, L., Borroto-Esoda, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02396-16 · Cited by 395
Paulussen, C., Hallsworth, J. E., Álvarez‐Pérez, S., Nierman, W. C., Hamill, P. G., Blain, D., Rediers, H., & Lievens, B. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12367 · Cited by 334
“components, secondary metabolites and drug transporters (Fanning and Mitchell, 2012).”
BackgroundLipner, S. R., & Scher, R. K. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.03.062 · Cited by 345
Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm
Papon, N., Courdavault, V., Clastre, M., & Bennett, R. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003550 · Cited by 314
“albicans from the end of the 20 century shed light on the molecular mechanisms involved in drug resistance [11], biofilm formation [12], adherence [13], yeasthyphal switching and its role in virulence [14], and sexual mating [15,16].”
BackgroundAn Update on Candida tropicalis Based on Basic and Clinical Approaches
Zuza-Alves, D. L., Silva-Rocha, W. P., & Chaves, G. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01927 · Cited by 295
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
Self-citationHöfs, S., Mogavero, S., & Hube, B. (2016) · Journal of Microbiology · doi:10.1007/s12275-016-5514-0 · Cited by 238
“nized abiotic surfaces, mucosal cell surfaces are a common biotic substrate for Candida biofilm formation (Fanning and Mitchell, 2012).”
BackgroundFungal Biofilms and Polymicrobial Diseases
Costa-Orlandi, C., Sardi, J., Pitangui, N., De Oliveira, H., Scorzoni, L., Galeane, M., Medina-Alarcón, K., Melo, W., Marcelino, M., Braz, J., et al. (2017) · Journal of Fungi · doi:10.3390/jof3020022 · Cited by 231
“Cells here exhibit increased resistance and different phenotypes compared to planktonic or free cells and are associated with the persistence of infections [4,13].”
BackgroundSilva-Dias, A., Miranda, I. M., Branco, J., Monteiro-Soares, M., Pina-Vaz, C., & Rodrigues, A. G. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00205 · Cited by 222
Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection
de Melo, W. C., Avci, P., de Oliveira, M. N., Gupta, A., Vecchio, D., Sadasivam, M., Chandran, R., Huang, Y.-Y., Yin, R., Perussi, L. R., et al. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.811861 · Cited by 205
Candida and Candidiasis—Opportunism Versus Pathogenicity: A Review of the Virulence Traits
Ciurea, C. N., Kosovski, I.-B., Mare, A. D., Toma, F., Pintea-Simon, I. A., & Man, A. (2020) · Microorganisms · doi:10.3390/microorganisms8060857 · Cited by 183
“albicans biofilms involves cell fusion and mating [89].”
BackgroundPolke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in Applied Microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 184
The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases
Bradford, L. L., & Ravel, J. (2017) · Virulence · doi:10.1080/21505594.2016.1237332 · Cited by 191
Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus
Martinez-Rossi, N. M., Bitencourt, T. A., Peres, N. T. A., Lang, E. A. S., Gomes, E. V., Quaresemin, N. R., Martins, M. P., Lopes, L., & Rossi, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01108 · Cited by 183
“The matrix that surrounds the microbial population acts as a physical barrier, protecting the microbial community against drugs and host immune response and contributing to the emergence of persistent cells, a subpopulation able to tolerate higher concentrations of drugs and considered to enable recalcitrance (Fanning…”
BackgroundShineh, G., Mobaraki, M., Perves Bappy, M. J., & Mills, D. K. (2023) · Applied Microbiology · doi:10.3390/applmicrobiol3030044 · Cited by 177
Reactive Oxygen Species-Inducing Antifungal Agents and Their Activity Against Fungal Biofilms
Delattin, N., Cammue, B. P., & Thevissen, K. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.189 · Cited by 189
Azole resistance mechanisms in Aspergillus: update and recent advances
Pérez-Cantero, A., López-Fernández, L., Guarro, J., & Capilla, J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.011 · Cited by 172
Update on Antifungal Drug Resistance
Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 174
Fabrication of Silver Nanoparticles Against Fungal Pathogens
Mansoor, S., Zahoor, I., Baba, T. R., Padder, S. A., Bhat, Z. A., Koul, A. M., & Jiang, L. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.679358 · Cited by 176
Candida auris: Disinfectants and Implications for Infection Control
Ku, T. S. N., Walraven, C. J., & Lee, S. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00726 · Cited by 177
“These include hyphal formation, adherence, phospholipase and proteinase production, and biofilm formation (Ghannoum, 2000; Berman and Sudbery, 2002; Saville et al., 2003; Fanning and Mitchell, 2012; Moyes et al., 2015).”
BackgroundAntifungal therapy with an emphasis on biofilms
Pierce, C. G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A. K., & López-Ribot, J. L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.008 · Cited by 173
“Other yeasts and filamentous fungi whose biofilm-forming ability associated with clinical settings has been described include Coccidioides, Pneumocystis, Malassezia, Penicillium, Histoplasma, Saccharomyces, Trichosporon, Blastoschizomyces, and some zygomycetes [5,15,26].”
Biofilm formation in medically important Candida species
Malinovská, Z., Čonková, E., & Váczi, P. (2023) · Journal of Fungi · doi:10.3390/jof9100955 · Cited by 167
Recent advances in topical carriers of anti-fungal agents
Garg, A., Sharma, G. S., Goyal, A. K., Ghosh, G., Si, S. C., & Rath, G. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04663 · Cited by 188
“Apart from Candida other filamentous fungi including Malassezia, Saccharomyces, Histoplasm, and Trichosporon also suggested to develop biofilm [27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39].”
BackgroundSelf-driven jamming in growing microbial populations
Delarue, M., Hartung, J., Schreck, C. F., Gniewek, P., Hu, L. Y., Herminghaus, S., & Hallatschek, O. (2016) · Nature Physics · doi:10.1038/nphys3741 · Cited by 141
Mechanisms and Impact of Biofilms and Targeting of Biofilms Using Bioactive Compounds—A Review
Samrot, A. V., Mohamed, A. A., Faradjeva, E., Jie, L. S., Sze, C. H., Arif, A., Sean, T. C., Michael, E. N., Mun, C. Y., Ng, X. Q., et al. (2021) · Medicina · doi:10.3390/medicina57080839 · Cited by 163
da Silva, A. R., de Andrade Neto, J. B., da Silva, C. R., Campos, R. D. S., Costa Silva, R. A., Freitas, D. D., do Nascimento, F. B. S. A., de Andrade, L. N. D., Sampaio, L. S., Grangeiro, T. B., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01846-15 · Cited by 139
“An important characteristic of Candida biofilms is resistance to antifungal agents, which can be intrinsic or acquired by the transfer of genetic material among biofilm cells (52), making new therapies necessary.”
BackgroundIn vitrocharacterization ofTrichophyton rubrumandT. mentagrophytesbiofilms
Costa-Orlandi, C. B., Sardi, J. D. C. O., Santos, C. T., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2014) · Biofouling · doi:10.1080/08927014.2014.919282 · Cited by 138
Tackling Fungal Resistance by Biofilm Inhibitors
Wu, S., Wang, Y., Liu, N., Dong, G., & Sheng, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01203 · Cited by 135
Emerging New Targets for the Treatment of Resistant Fungal Infections
Liu, N., Tu, J., Dong, G., Wang, Y., & Sheng, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01413 · Cited by 139
Neutrophil extracellular traps in fungal infection
Urban, C. F., & Nett, J. E. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.03.020 · Cited by 135
Srivastava, S., & Bhargava, A. (2015) · Biotechnology Letters · doi:10.1007/s10529-015-1960-8 · Cited by 131
Overcoming antifungal resistance
Srinivasan, A., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2014) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2014.02.005 · Cited by 143
Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?
Rossato, L., & Colombo, A. L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03081 · Cited by 121
“Biofilms are a common form of microbial growth that are crucial for the development of a broad spectrum of infections in the human host and also for defending pathogens from phagocytes and antimicrobial drugs (Fanning and Mitchell, 2012).”
BackgroundCutting through the complexity of cell collectives
Nadell, C. D., Bucci, V., Drescher, K., Levin, S. A., Bassler, B. L., & Xavier, J. B. (2013) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2012.2770 · Cited by 129
Virulence factors in fungal pathogens of man
Brunke, S., Mogavero, S., Kasper, L., & Hube, B. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.010 · Cited by 126
Major challenges and perspectives in the diagnostics and treatment of dermatophyte infections
Gnat, S., Łagowski, D., & Nowakiewicz, A. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14611 · Cited by 135
Elucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 127
Routine screening of harmful microorganisms in beach sands: Implications to public health
Sabino, R., Rodrigues, R., Costa, I., Carneiro, C., Cunha, M. A., Duarte, A., Faria, N. A., Ferreira, F. C., Gargaté, M. J., Júlio, C., et al. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.11.091 · Cited by 103
The role of biofilms in onychomycosis
Gupta, A. K., Daigle, D., & Carviel, J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.008 · Cited by 114
Aspergillus Biofilm In Vitro and In Vivo
Beauvais, A., & Latgé, J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0017-2015 · Cited by 113
“fumigatus biofilms are very different from yeast biofilms (6).”
BackgroundBrucker, K. D., Tan, Y., Vints, K., Cremer, K. D., Braem, A., Verstraeten, N., Michiels, J. J., Vleugels, J., Cammue, B. P. A., & Thevissen, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04650-14 · Cited by 107
Gabaldón, T., & Carreté, L. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fov110 · Cited by 99
Zieniuk, B., & Fabiszewska, A. U. (2018) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-018-2583-8 · Cited by 106
Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi
Hokken, M., Zwaan, B. J., Melchers, W. J. G., & Verweij, P. E. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103254 · Cited by 109
Li, P., Seneviratne, C. J., Alpi, E., Vizcaino, J. A., & Jin, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-15 · Cited by 95
“In particular, Candida species are notorious biofilm formers on indwelling medical devices, which is directly linked to therapeutic failure (3, 5).”
BackgroundAntifungal Compounds againstCandidaInfections from Traditional Chinese Medicine
Liu, X., Ma, Z., Zhang, J., & Yang, L. (2017) · BioMed Research International · doi:10.1155/2017/4614183 · Cited by 106
“Biofilm, buried in the extracellular matrix (ECM), holds a complicated three-dimensional architecture consisting mainly of yeast form cells and hyphal cells with broad heterogeneity in space [15, 109].”
BackgroundAntifungal activity of a prenylated flavonoid from Dalea elegans against Candida albicans biofilms
Peralta, M. A., da Silva, M. A., Ortega, M. G., Cabrera, J. L., & Paraje, M. G. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.07.003 · Cited by 98
Recent advances in delivery of antifungal agents for therapeutic management of candidiasis
Sawant, B., & Khan, T. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.127 · Cited by 109
Waste Gas Biofiltration: Advances and Limitations of Current Approaches in Microbiology
Ralebitso-Senior, T. K., Senior, E., Felice, R. D., & Jarvis, K. (2012) · Environmental Science & Technology · doi:10.1021/es203906c · Cited by 104
González-Ramírez, A. I., Ramírez‐Granillo, A., Medina‐Canales, M. G., Rodríguez-Tovar, A. V., & Martínez-Rivera, M. Á. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0859-4 · Cited by 101
Gamaletsou, M. N., Rammaert, B., Brause, B. D., Bueno, M. A., Dadwal, S., Henry, M. W., Katragkou, A., Kontoyiannis, D. P., McCarthy, M. W., Miller, A. O., et al. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00086-19 · Cited by 101
The physics of biofilms—an introduction
Mazza, M. G. (2016) · Journal of Physics D Applied Physics · doi:10.1088/0022-3727/49/20/203001 · Cited by 98
Surfactants of microbial origin as antibiofilm agents
Paraszkiewicz, K., Moryl, M., Płaza, G. A., Bhagat, D., Satpute, S., & Bernat, P. (2019) · International Journal of Environmental Health Research · doi:10.1080/09603123.2019.1664729 · Cited by 90
“Both yeast and filamentous fungi can also form biofilms; however, studies of fungal biofilms are limited compared to those of yeasts (Fanning and Mitchell 2012; Cavalheiro and Teixeira 2018).”
BackgroundRibeiro, F. D. C., de Barros, P. P., Rossoni, R. D., Junqueira, J. C., & Jorge, A. O. C. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13324 · Cited by 98
“BCR1 and CPH1) can contribute directly or indirectly to the adhesion and invasion processes (Finkel and Mitchell 2011; Fanning and Mitchell 2012; Nobile et al. 2012; Gulati and Nobile 2016).”
BackgroundStress-Tolerant Yeasts: Opportunistic Pathogenicity Versus Biocontrol Potential
Zajc, J., Gostinčar, C., Černoša, A., & Gunde-Cimerman, N. (2019) · Genes · doi:10.3390/genes10010042 · Cited by 87
“The formation of a biofilm is one of the most important virulence factors of a microorganism, as mature biofilms provide increased resilience to any attack by the host immune defenses, as well as to any administered antimicrobial agents [112,113].”
BackgroundWhat do we know about the biology of the emerging fungal pathogen of humans Candida auris?
Ruiz, G. B., & Lorenz, A. (2020) · Microbiological Research · doi:10.1016/j.micres.2020.126621 · Cited by 90
Ramírez‐Granillo, A., Medina‐Canales, M. G., Espindola, M. E. S., Martínez-Rivera, M. Á., Lucio, V. M. B., & Rodríguez-Tovar, A. V. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0363-2 · Cited by 92
“extracellular matrix (ECM) of macromolecules with changes in their cellular physiology, representing a differential expression of genes [2].”
BackgroundChin, V. K., Lee, T. Y., Basir, R., & Chong, P. P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101643 · Cited by 91
“elegans model has also often been used in the screening and development of new antifungal chemical compounds [81], to study Candida virulence factors [68], and to examine antifungal innate immunity [82].”
BackgroundMethodYeast biofilm in food realms: occurrence and control
Zara, G., Budroni, M., Mannazzu, I., Fancello, F., & Zara, S. (2020) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-020-02911-5 · Cited by 88
Microorganisms populating the water-related indoor biome
Babič, M. N., Gostinčar, C., & Gunde‐Cimerman, N. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10719-4 · Cited by 90
Delattin, N., Brucker, K. D., Vandamme, K., Meert, E. M. K., Marchand, A., Chaltin, P., Cammue, B. P. A., & Thevissen, K. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt449 · Cited by 89
Fungal Biofilms: Targets for the Development of Novel Strategies in Plant Disease Management
Villa, F., Cappitelli, F., Cortesi, P., & Kunova, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00654 · Cited by 92
“The formation of biofilms is not limited to the bacterial world, but rather includes fungal pathogens (Fanning and Mitchell, 2012; Borghi et al., 2015).”
BackgroundThe Significance of Lipids to Biofilm Formation in Candida albicans: An Emerging Perspective
Alim, D., Sircaik, S., & Panwar, S. L. (2018) · Journal of Fungi · doi:10.3390/jof4040140 · Cited by 85
“Apart from bacteria, fungi such as Candida, Cryptococcus, Aspergillus, Pneumocystis, and Coccidioides are also known to form biofilm [4].”
BackgroundYassin, M. T., Mostafa, A. A.-F., Al-Askar, A. A., & Bdeer, R. (2020) · European journal of medical research · doi:10.1186/s40001-019-0399-0 · Cited by 86
Kasza, K., Gurnani, P., Hardie, K. R., Cámara, M., & Alexander, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113973 · Cited by 80
Rana, K. L., Kour, D., Yadav, A. N., Yadav, N., & Saxena, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-444-64279-0.00016-5 · Cited by 83
Antifungal‐Inbuilt Metal–Organic‐Frameworks Eradicate Candida albicans Biofilms
Su, L., Li, Y., Liu, Y., Ma, R., Liu, Y., Huang, F., An, Y., Ren, Y., van der Mei, H. C., Busscher, H. J., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000537 · Cited by 79
Liu, Z., Li, M., Xie, Q., Liu, Y., Huang, J., Zeng, Q., Li, X., Rao, K., Ning, J., Zhao, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61519-1 · Cited by 90
de Mello, T. P., Aor, A. C., Gonçalves, D. D. S., Seabra, S. H., Branquinha, M. H., & dos Santos, A. L. S. (2016) · Biofouling · doi:10.1080/08927014.2016.1192610 · Cited by 71
Boral, H., Metin, B., Döğen, A., Seyedmousavi, S., & İlkit, M. (2017) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2017.10.008 · Cited by 76
“A mature biofilm is a three-dimensional structure that consists of yeast and hyphal forms in a polysaccharide/protein matrix with water channels (Fanning and Mitchell, 2012).”
BackgroundChi, M., Li, G., Liu, Y., Liu, G., Li, M., Zhang, X., Sun, Z., Sui, Y., & Liu, J. (2015) · Biological Control · doi:10.1016/j.biocontrol.2015.06.006 · Cited by 70
Novel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 78
Córdova-Alcántara, I. M., Venegas-Cortés, D. L., Martínez-Rivera, M. Á., Pérez, N. O., & Rodríguez-Tovar, A. V. (2019) · The Journal of Microbiology · doi:10.1007/s12275-019-8637-2 · Cited by 71
Guilhelmelli, F., Vilela, N., Simon, K. S., de Oliveira, M. A., Álvares, A. D. C. M., Rigonatto, M. C. L., Costa, P. H. D. S., Tavares, A. H., de Freitas, S. M., Nicola, A. M., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01844 · Cited by 74
Brucker, K. D., Delattin, N., Robijns, S., Steenackers, H. P. L., Verstraeten, N., Landuyt, B., Luyten, W. H. M. L., Schoofs, L., Dovgan, B., Fröhlich, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03045-14 · Cited by 70
“These biofilms are of great significance for public health, as they are critical in the development of clinical infections and are frequently refractory to conventional antimicrobial agents (5).”
BackgroundMolecular Characteristics and Biological Functions of Surface-Active and Surfactant Proteins
Sunde, M., Pham, C. L. L., & Kwan, A. H. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044847 · Cited by 66
Evidence for biofilms in onychomycosis
Gupta, A., & Foley, K. A. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06001-7 · Cited by 65
Ball, B., Bermas, A., Carruthers‐Lay, D., & Geddes‐McAlister, J. (2019) · Journal of Fungi · doi:10.3390/jof5020052 · Cited by 67
“Fungal biofilm formation provides an advantageous environment for microbial growth and survival through heightened resistance to environmental stressors, the host immune system, and therapeutics [35].”
BackgroundThe role of antifungals against Candida biofilm in catheter-related candidemia
Bouza, E., Guinea, J., & Guembe, M. (2014) · Antibiotics · doi:10.3390/antibiotics4010001 · Cited by 62
Virulence of Clinical Candida Isolates
Mroczyńska, M., & Brillowska‐Dąbrowska, A. (2021) · Pathogens · doi:10.3390/pathogens10040466 · Cited by 70
“Biofilm is an important virulence factor, responsible to prevent the antimycotic penetration through the matrix and therefore unregular antimycotics penetration into Candida cells [19,20], what leads to drug-tolerant and resistant mutants selection [20].”
BackgroundFungal Musculoskeletal Infections
Henry, M. W., Miller, A. O., Walsh, T. J., & Brause, B. D. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.01.006 · Cited by 65
Brilhante, R. S. N., Correia, E. E. M., Guedes, G. M. D. M., Pereira, V. S., de Oliveira, J. S., Bandeira, S. P., de Alencar, L. P., de Andrade, A. R. C., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., et al. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000528 · Cited by 60
“Based on these characteristics, biofilmforming ability is considered an important virulence factor for fungi [3] and, although most studies on fungal biofilms involve yeasts, it is known that dimorphic and filamentous fungi are also capable of forming such structures [5–8].”
BackgroundResultMartins‐Santana, L., Rezende, C. P., Rossi, A., Martinez-Rossi, N. M., & Almeida, F. B. D. R. (2023) · Pathogens · doi:10.3390/pathogens12020293 · Cited by 66
“This type of cellular organization makes cells less susceptible to antifungal action, increasing the resistance of this pathogen when cells aggregate into thin layers [40].”
BackgroundHigh-resolution mapping of cis -regulatory variation in budding yeast
Kita, R., Venkataram, S., Zhou, Y., & Fraser, H. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717421114 · Cited by 63
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 61
Collective motion conceals fitness differences in crowded cellular populations
Kayser, J., Schreck, C. F., Gralka, M., Fusco, D., & Hallatschek, O. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0734-9 · Cited by 58
“packed, for example microbial colonies and biofilms [39, 10, 41], or tissues and tumors in multi-cellular organisms [11, 29].”
Force Nanoscopy of Hydrophobic Interactions in the Fungal Pathogen Candida glabrata
El‐Kirat‐Chatel, S., Beaussart, A., Derclaye, S., Alsteens, D., Kucharíková, S., Dijck, P. V., & Dufrêne, Y. F. (2015) · ACS Nano · doi:10.1021/nn506370f · Cited by 60
Phylloplane Yeasts in Temperate Climates
Kemler, M., Witfeld, F., Begerow, D., & Yurkov, A. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-62683-3_6 · Cited by 61
Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs
Eldesouky, H. E., Mayhoub, A., Hazbun, T. R., & Seleem, M. N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00701-17 · Cited by 55
In Vitro and In Vivo Anti-Candida spp. Activity of Plant-Derived Products
Pedroso, R. D. S., Balbino, B. L., Andrade, G., Dias, M. C., Alvarenga, T. A., Pedroso, R. C. N., Pimenta, L. P., Lucarini, R., Pauletti, P. M., Januário, A. H., et al. (2019) · Plants · doi:10.3390/plants8110494 · Cited by 63
“Microbial biofilms are the main cause of hospital infections and the source of many recurrent and persistent diseases [4,5].”
BackgroundBiofilm Formation and Structure in the Filamentous Fungus Fusarium graminearum, a Plant Pathogen
Shay, R., Wiegand, A. A., & Trail, F. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00171-22 · Cited by 60
Molecular bases of antifungal resistance in filamentous fungi
Sharma, C., & Chowdhary, A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.018 · Cited by 55
Metadata
- Authors
- Fanning, S., & Mitchell, A. P.
- Affiliations
- Duke Medical Center (US)
- Carnegie Mellon University (US)
- Corresponding author
- Mitchell, Aaron P.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-05
- Volume
- 8
- Issue
- 4
- Pages
- e1002585
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3320593
- OpenAlex
- W3187158005
- Cited by
- 465
- References
- 30
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 30 · 2023: 46 · 2022: 32 · 2021: 41 · 2020: 43 · 2019: 41 · 2018: 24 · 2017: 36 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 15 · 2012: 6
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Andrew W. Mellon Foundation
- Richard King Mellon Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI067703)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- fungal biofilms, biofilm formation, fungal pathogens
- MeSH terms
- Antifungal Agents, Fungi, Species Specificity, Biofilms, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.